25 Oct 2022

PBS Website- 25th October 2022

The Utilisation Analysis Public Release Documents from the June 2022 Drug Utilisation Sub-Committee Meeting are now available.

25 Oct 2022

PBS Website- 25th October 2022

The Utilisation Analysis Public Release Documents from the June 2022 Drug Utilisation Sub-Committee Meeting are now available.

21 Oct 2022

PBS Website- 21st October 2022

Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 (Amendment Act) give effect to the commitments in the new Strategic Agreements with the medicines industry (2022-2027)

21 Oct 2022

PBS Website- 21st October 2022

Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 (Amendment Act) give effect to the commitments in the new Strategic Agreements with the medicines industry (2022-2027)

21 Oct 2022

PBS Website- 21st October 2022

Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 (Amendment Act) give effect to the commitments in the new Strategic Agreements with the medicines industry (2022-2027)

20 Oct 2022

PBS Website- 20th October 2022

The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised draft of the Pharmaceutical Benefits Scheme (PBS) Post-market Review (PMR) Framework.

20 Oct 2022

PBS Website- 20th October 2022

The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised draft of the Pharmaceutical Benefits Scheme (PBS) Post-market Review (PMR) Framework.

20 Oct 2022

PBS Website- 20th October 2022

The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised draft of the Pharmaceutical Benefits Scheme (PBS) Post-market Review (PMR) Framework.

14 Oct 2022

PBS Website- 14th October 2022

The outcomes from the September 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.

14 Oct 2022

PBS Website- 14th October 2022

The outcomes from the September 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.